Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01167595 · ClinicalTrials.gov registry record · NA
Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients
A NA study, sponsored by Clinical Evaluation Research Unit at Kingston General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,059
- Enrollment target
NCT01167595: Completed NA study, sponsored by Clinical Evaluation Research Unit at Kingston General Hospital.
NCT01167595 is a NA study that has completed, run by Clinical Evaluation Research Unit at Kingston General Hospital. The registered enrollment target is 1,059 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (25% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01167595, a NA study, has completed, sponsored by Clinical Evaluation Research Unit at Kingston General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,059 participants
- Enrollment target
Study Summary
Critically ill patients are consistently underfed. Feeding protocols are standardized system tools used to guide nutrition practices, but to date have failed to improve delivery of nutrition. The PEP uP Protocol is a new enhanced feeding protocol. Twenty North American Intensive Care Units (ICUs) will assess baseline nutrition practices. Ten ICUs will be randomized to implement the PEP uP Protocol and educational intervention, and ten will be randomized to continue usual care. Nutrition practices will be reevaluated 6 months after baseline. The investigators hypothesize that the PEP uP Protocol will increase delivery of nutrition, and may ultimately lead to improved survival of critical illness.
Primary Outcome
Total calories received from enteral nutrition/total prescription up to 12 evaluable ICU days
Interventions
- OTHER PEP uP Protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,059 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-11 |
| Phase | NA |
What the finished NCT01167595 record still lists
NCT01167595 is an interventional study that assigns participants to a tested intervention. Its 1,059 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (25% lower).
The record links to 0 conditions, and to 1 intervention - of which PEP uP Protocol is the first listed.
NCT01167595 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01167595 about?
NCT01167595 is a clinical study titled "Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients". Critically ill patients are consistently underfed. Feeding protocols are standardized system tools used to guide nutrition practices, but to date have failed to improve delivery of nutrition. The PEP uP Protocol is a new enhanced feeding protocol. Twenty North American Intensive Care Units (ICUs) wi...
What is the current status of trial NCT01167595?
This trial is currently completed. It is a NA study. The enrollment target is 1,059 participants. The study started on 2010-09. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01167595?
The interventions under investigation include: PEP uP Protocol (OTHER).
Who is sponsoring clinical trial NCT01167595?
This trial is sponsored by Clinical Evaluation Research Unit at Kingston General Hospital, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01167595's enrollment target sits among peer trials
1,059 98th of 2000 higher than 1,903 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05125302 · 1,059 participants · Phase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- NCT05520762 · 1,060 participants · NA
Hospital Airway Resuscitation Trial
- NCT05911568 · 1,060 participants
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
- NCT07140172 · 1,060 participants · NA
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia